Skip to main navigation Skip to search Skip to main content

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

  • Wei-Yu Lin
  • , Sarah E Fordham
  • , Eric Hungate
  • , Nicola J Sunter
  • , Claire Elstob
  • , Yaobo Xu
  • , Catherine Park
  • , Anne Quante
  • , Konstantin Strauch
  • , Christian Gieger
  • , Andrew Skol
  • , Thahira Rahman
  • , Lara Sucheston-Campbell
  • , Junke Wang
  • , Theresa Hahn
  • , Alyssa I Clay-Gilmour
  • , Gail L Jones
  • , Helen J Marr
  • , Graham H Jackson
  • , Tobias Menne
  • Mathew Collin, Adam Ivey, Robert K Hills, Alan K Burnett, Nigel H Russell, Jude Fitzgibbon, Richard A Larson, Michelle M Le Beau, Wendy Stock, Olaf Heidenreich, Abrar Alharbi, David J Allsup, Richard S Houlston, Jean Norden, Anne M Dickinson, Elisabeth Douglas, Clare Lendrem, Ann K Daly, Louise Palm, Kim Piechocki, Sally Jeffries, Martin Bornhäuser, Christoph Röllig, Heidi Altmann, Leo Ruhnke, Desiree Kunadt, Lisa Wagenführ, Heather J Cordell, Rebecca Darlay, Mette K Andersen, Maria C Fontana, Giovanni Martinelli, Giovanni Marconi, Miguel A Sanz, José Cervera, Inés Gómez-Seguí, Thomas Cluzeau, Chimène Moreilhon, Sophie Raynaud, Heinz Sill, Maria Teresa Voso, Francesco Lo-Coco, Hervé Dombret, Meyling Cheok, Claude Preudhomme, Rosemary E Gale, David Linch, Julia Gaal-Wesinger, Andras Masszi, Daniel Nowak, Wolf-Karsten Hofmann, Amanda Gilkes, Kimmo Porkka, Jelena D Milosevic Feenstra, Robert Kralovics, David Grimwade, Manja Meggendorfer, Torsten Haferlach, Szilvia Krizsán, Csaba Bödör, Friedrich Stölzel, Kenan Onel, James M Allan

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Abstract

Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we perform a meta-analysis of three genome-wide association studies, with replication in a fourth study, incorporating a total of 4018 AML cases and 10488 controls. We identify a genome-wide significant risk locus for AML at 11q13.2 (rs4930561; P = 2.15 × 10-8; KMT5B). We also identify a genome-wide significant risk locus for the cytogenetically normal AML sub-group (N = 1287) at 6p21.32 (rs3916765; P = 1.51 × 10-10; HLA). Our results inform on AML etiology and identify putative functional genes operating in histone methylation (KMT5B) and immune function (HLA).

Original languageEnglish
Article number6233
Pages (from-to)6233
JournalNature communications
Volume12
Issue number1
DOIs
Publication statusPublished - 29 Oct 2021

Keywords

  • Aldehyde Reductase/genetics
  • Case-Control Studies
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Genotype
  • HLA Antigens/genetics
  • Humans
  • Leukemia, Myeloid, Acute/genetics
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Reproducibility of Results
  • Whites/genetics

Fingerprint

Dive into the research topics of 'Genome-wide association study identifies susceptibility loci for acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this